Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
144

Summary

Conditions
  • Endometrial Carcinoma
  • Advanced Solid Tumors
  • Small Cell Lung Cancer
  • Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative
  • Cervical Carcinoma
  • Colorectal Carcinoma
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • Urothelial Carcinoma
  • Hepatocellular Carcinoma
  • Melanoma (Excluding Uveal Melanoma)
  • Undifferentiated Pleomorphic Sarcoma
  • Nasopharyngeal Carcinoma
  • Non Small Cell Lung Carcinoma
  • Squamous Cell Carcinoma of the Head and Neck
  • Pancreatic Carcinoma
  • Renal Cell Carcinoma
Type
Interventional
Phase
Phase 1
Design
Allocation: RandomizedIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03752398
Collaborators
ICON plc
Investigators
Study Director: David Liebowitz, MD Xencor, Inc.